Latest Regulatory News

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

BetMakers Technology Group has signed a definitive agreement to acquire Las Vegas Dissemination Company, gaining direct access to major Nevada casino operators and projecting $4.5 million revenue in the first year.

Emerald Resources has secured mining approval for its Dingo Range Gold Project in Western Australia and completed a major accommodation camp, marking significant progress toward its goal of becoming a multi-mine gold producer.

Forrestania Resources has launched a conditional all-scrip takeover offer for Kula Gold, valuing the company at approximately $42.7 million. The Kula board unanimously recommends acceptance, highlighting strategic regional consolidation and operational synergies.

Forrestania Resources has lodged a replacement bidder's statement for its off-market takeover offer of Kula Gold, offering 1 Forrestania share for every 5.6 Kula shares. The Kula board unanimously recommends acceptance, highlighting strategic benefits and operational synergies.

ActivePort Group Ltd is launching a pro-rata bonus option offer, granting shareholders 1 option per 5 shares held, exercisable at $0.04 and expiring in 2028. While no immediate funds will be raised, full exercise could inject over $9 million into the company.

New Frontier Minerals has completed a $2.25 million placement to professional investors, issuing over 107 million shares and promising additional attaching options early next year. This capital injection aims to accelerate exploration at its key projects in the Northern Territory and Queensland.

Kjerulf David Hastings Ainsworth has initiated an unconditional all-cash proportional takeover offer for 2.9% of Ainsworth Game Technology Ltd shares at $1.30 each, representing a significant premium over recent trading prices and a competing bid by Novomatic.

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.

Macquarie Group Limited has updated details for its interim dividend, confirming a fully franked payout of AUD 2.80 per share and setting the Dividend Reinvestment Plan price at AUD 195.34.

IPB Petroleum has signed a binding terms sheet to acquire a significant acreage position in Alaska’s National Petroleum Reserve, including the Umiat oil field, while raising $1.27 million to fund exploration and development studies.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.